PaulFLizzulMDPhD, MPH, MBA, FAAD
Dermatology • San Diego, CACosmetic Dermatology, Clinical Pharmacology, Clinical Informatics
Chief Medical Officer, AnaptysBio
Dr. Lizzul is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
AnaptysBio
10770 Wateridge circle
San Diego, CA 92121Phone+1 858-362-6292- Is this information wrong?
Summary
- Dr. Lizzul leads the AnaptysBio development organization, including clinical medicine, clinical operations, regulatory affairs, pharmacology and toxicology functions. Prior to AnaptysBio, he has served as Global Development Lead for Inflammation at Amgen, Chief Medical Officer of Sienna Biopharmaceuticals and Senior Medical Director at Kythera Biopharmaceuticals. Dr. Lizzul served as Assistant Professor of Dermatology and conducted clinical research at Tufts Medical Center. He is a board-certified dermatologist, a faculty member of the American Academy of Dermatology and has also served on the United States Food and Drug Administration (FDA) Dermatology and Ophthalmic Drugs Advisory Committee. Dr. Lizzul received his M.D., Ph.D. in molecular genetics and M.P.H. in epidemiology from the Robert Wood Johnson Medical School at Rutgers. He has also earned an M.B.A. in entrepreneurship from the Rutgers Business School.
Education & Training
University of California Davis HealthResidency, Dermatology, 2006 - 2009
Greenwich Hospital AssociationInternship, Internal Medicine, 2005 - 2006
Rutgers Robert Wood Johnson Medical SchoolClass of 2005, MD, PhD, MPH- University of California Davis HealthChief Residency, Dermatology
Rutgers Business SchoolMBA, Entrepreneurship
Certifications & Licensure
NJ State Medical License 2009 - 2025
MA State Medical License 2009 - 2025
FL State Medical License 2009 - 2025
CA State Medical License 2006 - 2025
CT State Medical License 2009 - 2024
NY State Medical License 2009 - 2024- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA Start of enrollment: 2016 Aug 01
Publications & Presentations
PubMed
- 11 citationsImsidolimab, an anti-interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis: results from the phase II GALLOP trial.Richard B Warren, Adam Reich, Andrzej Kaszuba, Waldemar Placek, Christopher E M Griffiths, Jihao Zhou, Bruce Randazzo, Paul Lizzul, Johann E Gudjonsson> ;The British Journal of Dermatology. 2023 Jul 17
- 25 citationsEfficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE TrialsSteven H. Dayan, Joel Schlessinger, Kenneth Beer, Lisa Donofrio, Derek H. Jones, Shannon Humphrey, Jean Carruthers, Paul F. Lizzul, Todd M. Gross, Frederick C. Bedding...> ;Aesthetic Surgery Journal. 2018 Aug 16
- 39 citationsOverview of ATX-101 (Deoxycholic Acid Injection): A Nonsurgical Approach for Reduction of Submental Fat.Steven H. Dayan, Shannon Humphrey, Derek H. Jones, Paul F. Lizzul, Todd M. Gross, Karen Stauffer, Frederick C. Beddingfield> ;Dermatologic Surgery. 2016 Nov 1
- Join now to see all
Press Mentions
AnaptysBio Reports HARP Phase 2 Top-Line Data of Imsidolimab in Moderate-to-Severe Hidradenitis SuppurativaSeptember 1st, 2022- AnaptysBio Presents Updated Data from Imsidolimab Phase 2 GALLOP Trial in Generalized Pustular PsoriasisOctober 2nd, 2021
Novel Topical Psoriasis Treatment Targets Nerve PathwaysJuly 10th, 2019- Join now to see all
Committees
- advisory committee member, FDA- DODAC 2010 - 2012
Professional Memberships
- Fellow
- Fellow
Hospital Affiliations
Olive View-UCLA Medical CenterSylmar, California
External Links
- Anaptysbiohttp://anaptysbio.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
